New therapies for castration-resistant prostate cancer.
Longo
Dan L
DL
D000726:Androgen Antagonists / Q000627:therapeutic use; D019496:Cancer Vaccines / Q000494:pharmacology / Q000627:therapeutic use*; D018929:Cell Culture Techniques; D016178:Granulocyte-Macrophage Colony-Stimulating Factor; D006801:Humans; D007167:Immunotherapy; D018799:Intercellular Adhesion Molecule-1 / Q000494:pharmacology / Q000627:therapeutic use*; D007963:Leukocytes, Mononuclear; D008297:Male; D011471:Prostatic Neoplasms / Q000276:immunology / Q000378:metabolism / Q000628:therapy*; D014020:Tissue Extracts / Q000494:pharmacology / Q000627:therapeutic use*
D000726:Androgen Antagonists; D019496:Cancer Vaccines; D014020:Tissue Extracts; D018799:Intercellular Adhesion Molecule-1; D016178:Granulocyte-Macrophage Colony-Stimulating Factor; C511774:sipuleucel-T